Stocks›Healthcare›UTHR

UTHR

United Therapeutics Corporation

NasdaqResearch view

Healthcare · Pharmaceutical Preparations · Large-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$21.2B

Enterprise Value$19.7B

Income$1.3B

Sales$3.2B

Book/sh$165.45

Cash/sh$36.30

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio6.28

Current Ratio6.60

Debt/Eq—

EPS (ttm)$27.86

EPS this Y13.1%

EPS past 3/5Y22.9%

Sales past 3/5Y18.0%

EPS Y/Y TTM13.1%

Sales Y/Y TTM10.6%

Shs Outstand42.89M

ROA16.9%

ROE18.8%

ROIC21.0%

Gross Margin87.9%

Oper. Margin46.9%

Profit Margin41.9%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$1.7B

2021

$1.9B

2022

$2.3B

2023

$2.9B

2024

$3.2B

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.7B	$1.9B	$2.3B	$2.9B	$3.2B
Gross Profit	$1.6B	$1.8B	$2.1B	$2.6B	$2.8B
Operating Income	$555.9M	$979.7M	$1.2B	$1.4B	$1.5B
Net Income	$475.8M	$727.3M	$984.8M	$1.2B	$1.3B
Diluted EPS	$10.06	$15.00	$19.81	$24.64	$27.86
Operating Cash Flow	$598.2M	$802.5M	$978.0M	$1.3B	$1.6B
Free Cash Flow	$477.4M	$663.7M	$747.6M	$1.1B	$1.0B